These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 1720490

  • 1. The product of the proto-oncogene c-kit (P145c-kit) is a human bone marrow surface antigen of hemopoietic precursor cells which is expressed on a subset of acute non-lymphoblastic leukemic cells.
    Bühring HJ, Ullrich A, Schaudt K, Müller CA, Busch FW.
    Leukemia; 1991 Oct; 5(10):854-60. PubMed ID: 1720490
    [Abstract] [Full Text] [Related]

  • 2. Characterization of hemopoietic cell populations from human cord blood expressing c-kit.
    Reisbach G, Bartke I, Kempkes B, Kostka G, Ellwart J, Birner A, Thalmeier K, Mailhammer R, Bornkamm GW, Ullrich A.
    Exp Hematol; 1993 Jan; 21(1):74-9. PubMed ID: 7678090
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Epitope mapping and functional studies with three monoclonal antibodies to the c-kit receptor tyrosine kinase, YB5.B8, 17F11, and SR-1.
    Ashman LK, Bühring HJ, Aylett GW, Broudy VC, Müller C.
    J Cell Physiol; 1994 Mar; 158(3):545-54. PubMed ID: 7510297
    [Abstract] [Full Text] [Related]

  • 5. AML: immunophenotypic heterogeneity and prognostic significance of c-kit expression.
    Reuss-Borst MA, Bühring HJ, Schmidt H, Müller CA.
    Leukemia; 1994 Feb; 8(2):258-63. PubMed ID: 7508533
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
    Drexler HG.
    Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Distribution of a hematopoietic-specific differentiation antigen of K562 cells in the human myeloid and lymphoid cell lineages.
    Clarke BJ, Liao SK, Leeds C, Soamboonsrup P, Neame PB.
    Cancer Res; 1987 Aug 15; 47(16):4254-9. PubMed ID: 3475169
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In vivo differentiation of mast cells from acute myeloid leukemia blasts carrying a novel activating ligand-independent C-kit mutation.
    Beghini A, Cairoli R, Morra E, Larizza L.
    Blood Cells Mol Dis; 1998 Jun 15; 24(2):262-70. PubMed ID: 9714703
    [Abstract] [Full Text] [Related]

  • 20. IL-4 regulates c-kit proto-oncogene product expression in human mast and myeloid progenitor cells.
    Sillaber C, Strobl H, Bevec D, Ashman LK, Butterfield JH, Lechner K, Maurer D, Bettelheim P, Valent P.
    J Immunol; 1991 Dec 15; 147(12):4224-8. PubMed ID: 1721642
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.